AMR Centre

Industry SectorBiotechnology

Deal TypeGrowth Investment

Dates2017

Website Linkwww.amrcentre.com

Overview

Based at Alderley Park, the Anti-Microbial Research Centre aims to accelerate the development of new antibiotics by providing development services to companies around the world in return for a commercial share from new products developed.

Why we like the business

Anti-microbial resistance is now recognised as a threat to humanity and the AMRC is a key part of the UK’s response to this global threat. AMRC is a founder partner of CARB-X, a US-based anti-microbial grant funder which is investing $455m into suitable projects around the world. The costs of AMRC’s unique development capabilities are significantly reduced thanks to CARB-X grants, while the scientific risks are reduced through access to the CARB-X panel of world leading experts.

Our Team

Hamish Graham

Contact us

Catapult Ventures / Catapult Ventures Group is a trading name of Catapult Ultimate Holdings Ltd, which is the ultimate holding company of Catapult Venture Managers Ltd, which is authorised and regulated by the Financial Conduct Authority.

This site uses Cookies to improve your user experience.By using this site you agree to these Cookies being set.